Literature DB >> 19810610

Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells.

Nikki Johnston1, Clive W Wells, Tina L Samuels, Joel H Blumin.   

Abstract

OBJECTIVES: Studies using combined multichannel intraluminal impedance with pH monitoring reveal a role for nonacidic reflux in laryngopharyngeal symptoms and injury. We have discovered that pepsin is taken up by laryngeal epithelial cells by receptor-mediated endocytosis. This finding reveals a novel mechanism by which pepsin could cause cell damage, potentially even in nonacidic refluxate. The objective of this study was to determine whether pepsin, at pH 7.4 and thus in nonacidic refluxate, causes cell damage.
METHODS: Cultured hypopharyngeal epithelial (FaDu) cells were exposed to human pepsin (0.1 mg/mL) at pH 7.4 for either 1 hour or 12 hours at 37 degrees C and analyzed by electron microscopy, cytotoxicity assay, and SuperArray.
RESULTS: We report mitochondrial and Golgi complex damage in cells exposed to pepsin at neutral pH, observed by electron microscopy. We also report cell toxicity of pepsin at pH 7.4, measured by a cytotoxicity assay. Furthermore, using SuperArray, we found that pepsin at pH 7.4 significantly alters the expression levels of multiple genes implicated in stress and toxicity.
CONCLUSIONS: These findings are perhaps the first to explain why many patients have symptoms and injury associated with nonacidic reflux, and could have important implications for the development of new therapies for reflux, such as pepsin receptor antagonists and/or irreversible inhibitors of peptic activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19810610     DOI: 10.1177/000348940911800913

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  26 in total

1.  Eye reflux: an ocular extraesophageal manifestation of gastric reflux.

Authors:  Danilo Mazzacane; Valerio Damiani; Michela Silvestri; Giorgio Ciprandi; Pierfranco Marino
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

2.  Airway reflux, cough and respiratory disease.

Authors:  Ian D Molyneux; Alyn H Morice
Journal:  Ther Adv Chronic Dis       Date:  2011-07       Impact factor: 5.091

3.  Effect of different pH criteria on dual-sensor pH monitoring in the evaluation of supraesophageal gastric reflux in children.

Authors:  Eric Chiou; Rachel Rosen; Samuel Nurko
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-04       Impact factor: 2.839

Review 4.  How to Approach Laryngopharyngeal Reflux: An Otolaryngology Perspective.

Authors:  Vaninder K Dhillon; Lee M Akst
Journal:  Curr Gastroenterol Rep       Date:  2016-08

5.  Respiratory and laryngeal symptoms secondary to gastro-oesophageal reflux.

Authors:  G Rafferty; I Mainie; L P A McGarvey
Journal:  Frontline Gastroenterol       Date:  2011-05-04

6.  Relevance of GERD in lung transplant patients.

Authors:  Veerle Mertens; Lieven Dupont; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2010-06

7.  Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.

Authors:  Tina Samuels; Craig Hoekzema; Jon Gould; Matthew Goldblatt; Matthew Frelich; Matthew Bosler; Sang-Hyuk Lee; Nikki Johnston
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-06-15       Impact factor: 1.547

8.  Simulated reflux decreases vocal fold epithelial barrier resistance.

Authors:  Elizabeth Erickson; Mahalakshmi Sivasankar
Journal:  Laryngoscope       Date:  2010-08       Impact factor: 3.325

9.  Diagnosis of supra-esophageal gastric reflux: correlation of oropharyngeal pH with esophageal impedance monitoring for gastro-esophageal reflux.

Authors:  E Chiou; R Rosen; H Jiang; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2011-05-18       Impact factor: 3.598

10.  Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells.

Authors:  Nikki Johnston; Justin C Yan; Craig R Hoekzema; Tina L Samuels; Gary D Stoner; Joel H Blumin; Jonathan M Bock
Journal:  Laryngoscope       Date:  2012-05-08       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.